There are NIH programs presently underway to address both the opioid addiction problem and the pain problem.
“Safe and effective therapeutics to treat pain without risk of addiction are vital tools for addressing the opioid crisis in the long term. The HEAL initiative research has advanced several promising therapeutic candidates, including a new nonopioid approach to treat neuropathic pain that received an investigational new drug approval from the US Food and Drug Administration (FDA). In addition, the HEAL initiative investigators have patented novel targets for chronic pain and migraine, inflammatory pain, and visceral pain.”
We know the problem and we’re working on it.